Transactivation of vimentin by β-catenin in human breast cancer cells

Cancer Research

Volumn 63, Issue 10, 2003, Pages 2658-2664

  Gilles, Christine ^a   Polette, Myriam ^b   Mestdagt, Mélanie ^a   Nawrocki Raby, Béatrice ^b   Ruggeri, Philippe ^a   Birembaut, Philippe ^b   Foidart, Jean Michel ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b HÔPITAL MAISON BLANCHE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; LYMPHOID ENHANCER FACTOR 1; VIMENTIN;

ARTICLE; BINDING KINETICS; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYME CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; TRANSACTIVATION; UPREGULATION;

BETA CATENIN; BREAST NEOPLASMS; CELL NUCLEUS; CYTOPLASM; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROMOTER REGIONS (GENETICS); TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; VIMENTIN;

EID: 0037504665     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Gilles, C., and Thompson, E. W. The epithelial to mesenchymal transition and metastatic progression in carcinoma. Breast J., 2: 83-96, 1996.
2. Savagner, P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays, 23: 912-923, 2001.
3. Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer, 2: 442-454, 2002.
4. Van Aken, E., De Wever, O., Correia da Rocha, A. S., and Mareel, M. Defective E-cadherin/catenin complexes in human cancer. Virchows Arch., 439: 725-751, 2001.
5. Hecht, A., and Kemler, R. Curbing the nuclear activities of β-catenin. Control over Wnt target gene expression. EMBO Rep., 1: 24-28, 2000.
6. Gottardi, C. J., and Gumbiner, B. M. Adhesion signaling: how β-catenin interacts with its partners. Curr. Biol., 11: R792-R794, 2001.
7. Behrens, J., von Kries, J. P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. Functional interaction of β-catenin with the transcription factor LEF-1. Nature (Lond.), 382: 638-642, 1996.
8. Conacci-Sorrell, M., Zhurinsky, J., and Ben Ze'ev. A. The cadherin-catenin adhesion system in signaling and cancer. J. Clin. Investig., 109: 987-991, 2002.
9. Brabletz, T., Jung, A., Dag, S., Hlubek, F., and Kirchner, T. β-Catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am. J. Pathol., 155: 1033-1038, 1999.
10. Crawford, H. C., Fingleton, B. M., Rudolph-Owen, L. A., Goss, K. J., Rubinfeld, B., Polakis, P., and Matrisian, L. M. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene, 18: 2883-2891, 1999.
11. Crawford, H. C., Fingleton, B., Gustavson, M. D., Kurpios, N., Wagenaar, R. A., Hassell, J. A., and Matrisian, L. M. The PEA3 subfamily of Ets transcription factors synergizes with β-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol. Cell. Biol., 21: 1370-1383, 2001.
12. Mann, B., Gelos, M., Siedow, A., Hanski, M. L., Gratchev, A., Ilyas, M., Bodmer, W. F., Moyer, M. P., Riecken, E. O., Buhr, H. J., and Hanski, C. Target genes of β-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc. Natl. Acad. Sci. USA, 96: 1603-1608, 1999.
13. Wielenga, V. J., Smits, R., Korinek, V., Smit, L., Kielman, M., Fodde, R., Clevers, H., and Pals, S. T. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am. J. Pathol., 154: 515-523, 1999.
14. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Identification of c-MYC as a target of the APC pathway. Science (Wash. DC), 281: 1509-1512, 1998.
15. Tetsu, O., and McCormick, F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (Lond.), 398: 422-426, 1999.
16. Roose, J., Huls, G., van Beest, M., Moerer, P., van der, H. K., Goldschmeding, R., Logtenberg, T., and Clevers, H. Synergy between tumor suppressor APC and the β-catenin-Tcf4 target Tcf1. Science (Wash. DC), 285: 1923-1926. 1999.
17. Gradl, D., Kuhl, M., and Wedlich, D. The Wnt/Wg signal transducer β-catenin controls fibronectin expression. Mol. Cell. Biol., 19: 5576-5587, 1999.
18. Vallin, J., Thuret, R., Giacomello, E., Faraldo, M. M., Thiery, J. P., and Broders, F. Cloning and characterization of three Xenopus slug promoters reveal direct regulation by Lef/β-catenin signaling. J. Biol. Chem., 276: 30350-30358, 2001.
19. Hlubek, F., Jung, A., Kotzor, N., Kirchner, T., and Brabletz, T. Expression of the invasion factor laminin γ2 in colorectal carcinomas is regulated by β-catenin. Cancer Res., 61: 8089-8093, 2001.
20. Steinert, P. M., and Roop, D. R. Molecular and cellular biology of intermediate filaments. Annu. Rev. Biochem., 57: 593-625, 1988.
21. Ramaekers, F. C., Haag, D., Kant, A., Moesker, O., Jap, P. H., and Vooijs, G. P. Coexpression of keratin- and vimentin-type intermediate filaments in human metastatic carcinoma cells. Proc. Natl. Acad. Sci. USA, 80: 2618-2622, 1983.
22. Guarino, M. Epithelial-to-mesenchymal change of differentiation. From embryogenetic mechanism to pathological patterns. Histol. Histopathol., 10: 171-184, 1995.
23. Gilles, C., Polette, M., Piette, J., Delvigne, A. C., Thompson, E. W., Foidart, J. M., and Birembaut, P. Vimentin expression in cervical carcinomas: association with invasive and migratory potential. J. Pathol., 180: 175-180, 1996.
24. Gilles, C., Polette, M., Zahm, J. M., Tournier, J. M., Volders, L., Foidart, J. M., and Birembaut, P. Vimentin contributes to human mammary epithelial cell migration. J. Cell Sci., 112 (Pt 24): 4615-4625, 1999.
25. Hendrix, M. J., Seftor, E. A., Seftor, R. E., and Trevor, K. T. Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am. J. Pathol., 150: 483-495, 1997.
26. Eckes, B., Dogic, D., Colucci-Guyon, E., Wang, N., Maniotis, A., Ingber, D., Merckling, A., Langa, F., Aumailley, M., Delouvee, A., Koteliansky, V., Babinet, C., and Krieg, T. Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. J. Cell Sci., 111 (Pt 13): 1897-1907, 1998.
27. Eckes, B., Colucci-Guyon, E., Smola, H., Nodder, S., Babinet, C., Krieg, T., and Martin, P. Impaired wound healing in embryonic and adult mice lacking vimentin. J. Cell Sci., 113: 2455-2462, 2000.
28. Svitkina, T. M., Verkhovsky, A. B., and Borisy, G. G. Plectin sidearms mediate interaction of intermediate filaments with microtubules and other components of the cytoskeleton. J. Cell Biol., 135: 991-1007, 1996.
29. Maniotis, A. J., Chen, C. S., and Ingber, D. E. Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc. Natl. Acad. Sci. USA, 94: 849-854, 1997.
30. 4 cytoplasmic tail. J. Cell Sci., 111 (Pt 18): 2717-2728, 1998.
31. Goldman, R. D., Chou, Y. H., Prahlad, V., and Yoon, M. Intermediate filaments: dynamic processes regulating their assembly, motility, and interactions with other cytoskeletal systems. FASEB J., 13 (Suppl. 2): S261-S265, 1999.
32. Wu, A. L., Wang, J., Zheleznyak, A., and Brown, E. J. Ubiquitin-related proteins regulate interaction of vimentin intermediate filaments with the plasma membrane. Mol. Cell. 4: 619-625, 1999.
33. Gonzales, M., Weksler, B., Tsuruta, D., Goldman, R. D., Yoon, K. J., Hopkinson, S. B., Flitney, F. W., and Jones, J. C. Structure and function of a vimentin-associated matrix adhesion in endothelial cells. Mol. Biol. Cell, 12: 85-100, 2001.
34. Goldman, R. D., Khuon, S., Chou, Y. H., Opal, P., and Steinert, P. M. The function of intermediate filaments in cell shape and cytoskeletal integrity. J. Cell Biol., 134: 971-983, 1996.
35. Hendrix, M. J., Seftor, E. A., Chu, Y. W., Trevor, K. T., and Seftor, R. E. Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev., 15: 507-525, 1996.
36. Sommers, C. L., Byers, S. W., Thompson, E. W., Torri, J. A., and Gelmann, E. P. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res. Treat., 31: 325-335, 1994.
37. Polette, M., Gilles, C., de Bentzmann, S., Gruenert, D., Tournier, J. M., and Birembaut, P. Association of fibroblastoid features with the invasive phenotype in human bronchial cancer cell lines. Clin. Exp. Metastasis, 16: 105-112, 1998.
38. Martel, C., Harper, F., Cereghini, S., Noe, V., Mareel, M., and Cremisi, C. Inactivation of retinoblastoma family proteins by SV40 T antigen results in creation of a hepatocyte growth factor/scatter factor autocrine loop associated with an epithelial-fibroblastoid conversion and invasiveness. Cell Growth Differ., 8: 165-178, 1997.
39. Rittling, S. R., and Baserga, R. Functional analysis and growth factor regulation of the human vimentin promoter. Mol. Cell. Biol., 7: 3908-3915, 1987.
40. Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., and Clevers, H. Constitutive transcriptional activation by β-catenin-Tcf complex in APC-/- colon carcinoma. Science (Wash. DC), 275: 1784-1787, 1997.
41. van de Wetering, M., W. M., Cavallo, R., Dooijes, D., van Beest, M., van Es, J., Loureiro, J., Ypma, A., Hursh, D., Jones, T., Bejsovec, A., Peifer, M., Mortin, M., and Clevers, H. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell, 88: 789-799, 1997.
42. Orford, K., Crockett, C., Jensen, J. P., Weissman, A. M., and Byers, S. W. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J. Biol. Chem., 272: 24735-24738, 1997.
43. Sommers, C. L., Walker-Jones, D., Heckford, S. E., Worland, P., Valverius, E., Clark. R., McCormick, F., Stampfer, M., Abularach, S., and Gelmann, E. P. Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells. Cancer Res., 49: 4258-4263, 1989.
44. Sommers, C. L., Thompson, E. W., Torri, J. A., Kemler, R., Gelmann, E. P., and Byers, S. W. Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. Cell Growth Differ., 2: 365-372, 1991.
45. Thompson, E. W., Paik, S., Brunner, N., Sommers, C. L., Zugmaier, G., Clarke, R., Shima, T. B., Torri, J., Donahue, S., and Lippman, M. E. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J. Cell Physiol, 150: 534-544, 1992.
46. Muller, T., Choidas, A., Reichmann, E., and Ullrich, A. Phosphorylation and free pool of β-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. J. Biol. Chem., 274: 10173-10183, 1999.
47. Eger, A., Stockinger, A., Schaffhauser, B., Beug, H., and Foisner, R. Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of β-catenin and upregulation of β-catenin/lymphoid enhancer binding factor-1 transcriptional activity. J. Cell Biol., 148: 173-188, 2000.
48. Reichert, M., Muller, T., and Hunziker, W. The PDZ domains of zonula occludens-1 induce an epithelial to mesenchymal transition of Madin-Darby canine kidney I cells. Evidence for a role of β-catenin/Tcf/Lef signaling. J. Biol. Chem., 275: 9492-9500, 2000.
49. Kim, K., Lu, Z., and Hay, E. D. Direct Evidence for a Role of β-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol. Int., 26: 463-476, 2002.
50. Murakami, T., Toda, S., Fujimoto, M., Ohtsuki, M., Byers, H. R., Etoh, T., and Nakagawa, H. Constitutive activation of Wnt/β-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential. Biochem. Biophys. Res. Commun., 288: 8-15, 2001.
51. van de Wetering, M., Barker, N., Harkes, I. C., van der Heyden, M., Dijk, N. J., Hollestelle, A., Klijn, J. G., Clevers, H., and Schutte, M. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling. Cancer Res., 61: 278-284, 2001.
52. Rittling, S. R., Coutinho, L., Amram, T., and Kolbe, M. AP-1/jun binding sites mediate serum inducibility of the human vimentin promoter. Nucleic Acids Res., 17: 1619-1633, 1989.
53. Van de Klundert, F. A., van Eldik, G. J., Pieper, F. R., Jansen, H. J., and Bloemendal, H. Identification of two silencers flanking an AP-1 enhancer in the vimentin promoter. Gene (Amst.), 122: 337-343, 1992.
54. Lilienbaum, A., and Paulin, D. Activation of the human vimentin gene by the Tax human T-cell leukemia virus. I. Mechanisms of regulation by the NF-κB transcription factor. J. Biol. Chem., 268: 2180-2188, 1993.
55. Salvetti, A., Lilienbaum, A., Li, Z., Paulin, D., and Gazzolo, L. Identification of a negative element in the human vimentin promoter: modulation by the human T-cell leukemia virus type I Tax protein. Mol. Cell. Biol., 13: 89-97, 1993.
56. Van de Klundert, F. A., Jansen, H. J., and Bloemendal, H. Negative regulation of a special, double AP-1 consensus element in the vimentin promoter: interference by the retinoic acid receptor. J. Cell. Physiol., 164: 85-92, 1995.
57. Chen, J. H., Vercamer, C., Li, Z., Paulin, D., Vandenbunder, B., and Stehelin, D. PEA3 transactivates vimentin promoter in mammary epithelial and tumor cells. Oncogene, 13: 1667-1675, 1996.
58. Moura-Neto, V., Kryszke, M. H., Li, Z., Vicart, P., Lilienbaum, A., and Paulin, D. A 28-bp negative element with multiple factor-binding activity controls expression of the vimentin-encoding gene. Gene (Amst.), 168: 261-266, 1996.
59. Izmailova, E. S., and Zehner. Z. E. An antisilencer element is involved in the transcriptional regulation of the human vimentin gene. Gene (Amst.), 230: 111-120, 1999.
60. Wieczorek, E., Lin, Z., Perkins, E. B., Law, D. J., Merchant, J. L., and Zehner, Z. E. The zinc finger repressor. ZBP-89, binds to the silencer element of the human vimentin gene and complexes with the transcriptional activator, Spl. J. Biol. Chem., 275: 12879-12888, 2000.
61. Pieper, F. R., Van de Klundert, F. A., Raats, J. M., Henderik, J. B., Schaart, G., Ramaekers, F. C., and Bloemendal, H. Regulation of vimentin expression in cultured epithelial cells. Eur. J. Biochem., 210: 509-519, 1992.
62. Sommers, C. L., Skerker, J. M., Chrysogelos, S. A., Bosseler, M., and Gelmann, E. P. Regulation of vimentin gene transcription in human breast cancer cell lines. Cell Growth Differ., 5: 839-846, 1994.
63. Cavallo, R. A., Cox, R. T., Moline, M. M., Roose, J., Polevoy, G. A., Clevers, H., Peifer, M., and Bejsovec, A. Drosophila Tcf and Groucho interact to repress Wingless signalling activity. Nature (Lond.), 395: 604-608, 1998.
64. Levanon, D., Goldstein, R, E., Bernstein, Y., Tang, H., Goldenberg, D., Stifani, S., Paroush, Z., and Groner, Y. Transcriptional repression by AML1 and LEF-1 is mediated by theTLE/Groucho corepressors. Proc. Natl. Acad. Sci. USA, 95: 11590-11595, 1998.